Isoaspartyl post-translational modification triggers anti-tumor T and B lymphocyte immunity. (Q40236620)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950786%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Isoaspartyl post-translational modification triggers anti-tumor T and B lymphocyte immunity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950786%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950786%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Hester A Doyle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950786%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Jing Zhou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950786%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Bohdan P Harvey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950786%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Robert M Roman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950786%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Renelle J Gee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950786%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Raymond A Koski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950786%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Mark J Mamula

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950786%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

1 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950786%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biological Chemistry

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950786%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

281

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950786%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950786%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

32676-32683

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950786%20AND%20SRC:MED&resulttype=core&format=json

Protein carboxyl methyltransferases: two distinct classes of enzymes

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

DNA fusion vaccines induce targeted epitope-specific CTLs against minor histocompatibility antigens from a normal or tolerized repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

Post-translational protein modifications in antigen recognition and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

Presence and localization of T-cell subsets in relation to melanocyte differentiation antigen expression and tumour regression as assessed by immunohistochemistry and molecular analysis of microdissected T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillanc

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

Coupling and uncoupling of tumor immunity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

Turning on/off tumor-specific CTL response during progressive tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

Dendritic cells as therapeutic vaccines against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

Boosting vaccinations with peptide-pulsed CD34+ progenitor-derived dendritic cells can expand long-lived melanoma peptide-specific CD8+ T cells in patients with metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

Limited infiltration of exogenous dendritic cells and naive T cells restricts immune responses in peripheral lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M604847200

21 January 2018

Identifiers

DOI

10.1074/JBC.M604847200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950786%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950786%20AND%20SRC:MED&resulttype=core&format=json